Search results
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 1 day agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
OCT Europe: Unless everyone is benefiting, what is the point?
Pharmaceutical Technology via Yahoo Finance· 10 hours agoPatient-centricity has been a buzzword in the clinical trial industry for the past few years with...
Nuvectis Pharma executive buys $3,145 in company stock By Investing.com
Investing.com· 2 days agoIn a recent move that signals confidence in the company, Enrique Poradosu, Chief Science & Business...
eschbach Launches Shiftconnector Equipment Hub to Streamline Regulatory Compliance in the...
Digital Journal· 1 day agoShiftconnector® incorporates AI technology and helps manufacturing teams take charge of operational efficiencies, safety, asset performance, and product quality. eschbach ...
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing -...
Benzinga via Yahoo Finance· 5 days agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
Altera raises $9m in seed round to fund AI software
gamesindustry.biz· 6 days agoAI startup Altera has raised $9 million in a seed round, co-led by Patron and First Spark Ventures. The company intends to use these funds to improve its artificial intelligence ...
Axios AI+
Axios· 7 days agoBiosecurity experts say AI-driven "biosurveillance" could help spot the next pandemic or biological attack. The big picture: An initial surge of concern over the threat from ...
Kexing Biopharm Teams Up with Qingfeng Pharma for the Global Market on Olaparib Tablets
Digital Journal· 6 days agoLaunches LAUREL, an AI-Powered Press Release Generation Tool Equinox Gold Publishes 2023 ESG Report More from Digital Journal Let’s waltz! Vienna ball...
Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024
BioPharma-Reporter· 8 hours agoBPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we...
Earnings call: OptimizeRx reports robust Q1 growth, driven by DAAP demand By Investing.com
Investing.com· 5 hours agoOptimizeRx Corporation (NASDAQ:OPRX), a leading provider of digital health messaging via electronic...
